GlassScriptPhysician profile
Anthony J Lutz
NPI 1669705687
$3,420.00
in general payments reported to CMS, 2019-2025
22 companies · $1,976 in 2025
The $1,976 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $166 · 2021: $122 · 2022: $177 · 2023: $225 · 2024: $593 · 2025: $1,976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684 · Travel and Lodging: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.46 |
| Travel and Lodging | $1,109.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,684.88 | 2024-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.18 | 2020-2025 | Lifevest |
| Medtronic, INC. | $225.18 | 2021-2025 | Micra |
| Boston Scientific Corporation | $197.16 | 2023-2025 | Cds - Mct/Cem Monitoring |
| Novartis Pharmaceuticals Corporation | $168.42 | 2023-2024 | |
| Amgen INC. | $143.08 | 2022-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $131.67 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $114.61 | 2019 | |
| United Therapeutics Corporation | $109.50 | 2025 | |
| Pfizer INC. | $51.79 | 2022-2024 | |
| Cordis US Corp. | $41.31 | 2025 | Mynx Control, Mynxgrip |
| Lantheus Medical Imaging, INC. | $37.80 | 2019-2022 | |
| Preventice Services, LLC | $37.56 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $36.11 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $34.25 | 2023-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $33.23 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $30.04 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Siemens Medical Solutions USA, INC. | $28.53 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Bard Peripheral Vascular, INC. | $28.24 | 2024 | Halo One Thin-Walled Guiding Sheath |
| Teleflex LLC | $23.43 | 2024 | Guideliner |
| Tactile Systems Technology INC | $20.12 | 2024 | Flexitouch Plus, Entre Plus |
| Terumo Medical Corporation | $13.91 | 2024 | Glidesheath Slender, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.